Study of mineralization of lithium calcium phosphosilicate glass ceramics in vivo during bone tissue regeneration

Abstract

Prospective directions for the creation of biologically active substitutes for bone tissue were analyzed. The effectiveness of the use of calcium phosphosilicate materials modified with CuO, ZnO, Ag2O, Fe2O3, TiO2, SrO and Nb2O5 to ensure high biocompatibility and antibacterial properties of bone endoprostheses has been established. The prospective use of lithium calcium phosphate silicate glass ceramics for obtaining strengthened, biologically active bone implants was substantiated. The main criteria for the development of biocompatible glass-ceramic materials regarding their composition, structure, texture, and surface properties have been established. The influence of differences in the structure and resorption of calcium phosphosilicate glass ceramics on the mechanism of formation of an apatite-like layer in vivo was analyzed. The features of mineralization of calcium phosphosilicate glass ceramics in vivo during bone tissue regeneration were determined, and the effectiveness of the use of glass ceramics based on hydroxyapatite and lithium disilicate in bone tissue replacement was established to reduce the rehabilitation period and long-term use of endoprostheses under variable loads. The developed OS-7 calcium phosphosilicate glass-ceramic material is characterized by the content of crystalline phases of 10 vol.% lithium disilicate and 55 vol.% hydroxyapatite with a ratio of CaO/P2O5=1.67, surface microrelief of 6 m, surface free energy value of 75 mJ/m2 and crack resistance of 6.0 MPam1/2. This material is biocompatible due to the formation of carbonate hydroxyapatite crystals already on the 14th day, which allows us to consider its promising use in the treatment of fractures, defects of long bones and in the replacement of short or tubular bones.